Health Precincts Biobank (for researchers)

Health_Precincts_Biobank_services

 

 

Health Precincts Biobank Specimen Catalogue

The Health Precincts Biobank Specimen Catalogue is now searchable in real time. 

 

 
 

How to get access to samples:

Search the catalogue here to estimate the availability of sample types for your study. The number and availability of samples will be confirmed by the Health Precincts Biobank team. Follow the steps below to submit an inquiry through the online form accessed via the specimen catalogue.

Step 1: Use the Filters on the left of the screen to see available specimens, the search will update as additional Filters are selected. To remove a Filter from your search select the cross adjacent to the Filter name or uncheck the Filter term. Select your specimens of interest and add into a cart using the green + Add to Cart button on the top right of the screen.

Step 2: Click the blue Cart button to review your selection, you can continue searching or press the blue Submit Request button to proceed to the Request Confirmation page.

Step 3: Complete your details including information about the specimens you are interested in and click the blue Submit Request button. A member of the Health Precincts Biobank team will be in touch to discuss your request and take you through the full application process.

Step 4: Once we determine if we can meet your research needs you will need to submit a full application including your HREC approval and our Research Access Committee will then assess your request. We will also provide you with a quote.

Step 5: Prior to specimen and/or data distribution your institution will be required to sign a Material Transfer Agreement (external researchers) or an Internal User Agreement (UNSW researchers).

Select Biobank Publications

  • Kang EY, Millstein J, Popovic G. et al. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma. Virchows Arch (2021) 480(4): 855-871. PMID: 34782936 
  • Liu D, Enriquez L & Ford CE. ROR2 Is Epigenetically Regulated in Endometrial Cancer. Cancers (2021) 13(3): 383. PMID: 33494187 
  • Quinn CM, Porwal M, Meagher NS, Hettiaratchi A, Power C, Jonnaggadala J, McCullough S, Macmillan S, Tang K, Liauw W, Goldstein D, Zeps N & Crowe PJ. Moving with the Times: The Health Science Alliance (HSA) Biobank Pathway to Sustainability. Biomarker Insights (2021), 16: 1-10. PMID: 35173407 
  • Xu X, Wang Y, Bryce N, Tang K, Meagher NS, Kang EY, Kelemen LE, Köbel M, Ramus SJ, Friedlander M, Ford CE, Hardeman EC & Gunning PW. Targeting the actin/tropomyosin cytoskeleton in epithelial ovarian cancer reveals multiple mechanisms of synergy with anti-microtubule agents.  Br J Cancer (2021) 125(2): 265-276. PMID: 33981016
  • Sharbeen G, McCarroll J, Akerman A, Kopecky C, Youkhana J, Holst J, Boyer C, Erkan M, Goldstein D, Timpson P, Cox T, Pereira B, Chitty J, Fey S, Najumudeen A, Campbell A, Sansom O, Ignacio R, Naim S, Liu J, Russia N, Lee J, Chou A, Johns A, Gill A, Gonzales-Aloy E, Kokkinos J, Gebski V, Turner N, Apte M, Davis T, Morton J, Haghighi K, Australian Pancreatic Cancer Genome Initiative, Phillips P. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to SLC7A11 inhibition. Cancer Research (2021) 81(3): 3461-3479. PMID: 33980655 
  • Kokkinos J, Sharbeen G, Haghighi KS, Ignacio RMC, Kopecky C, Gonzales-Aloy E, Youkhana J, Timpson P, Pereira BA, Ritchie S, Pandzic E, Boyer C, Davis TP, Butler LM, Goldstein D, McCarroll JA & Phillips PA. Ex vivo culture of intact human patient derived pancreatic tumour tissue. Scientific Reports (2021), 11, 1944.  PMID: 33479301 
  • Yao J, Zhu X, Jonnagaddala J, Hawkins N & Huang J. Whole slide images-based cancer survival prediction using attention guided deep multiple instance learning networks. Medical Image Analysis (2020), 65. PMID: 32739769
  • Udugama M, Sanij E, Voon HPJ, Son J, Hii L, Henson JD, Chan FL, Chang FTM, Liu Y, Pearson RB, Kalitsis P, Mann JR, Collas P, Hannan RD & Wong LH. Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancers. Proceedings of the National Academy of Sciences (2018), 115 (18) 4737-4742; PMID: 29669917
  • Henry CE, Llamosas E, Daniels B, Coopes A, Tang K, Ford CE. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer. Gynecologic Oncology (2018), 148(3):576-584. PMID: 29395309 

Selected research projects supported by the Health Precincts Biobank

Brief project title 

Researcher institution 

The role of ROR1 and ROR2 in endometrial cancer 

UNSW Sydney 

The immune response to myelodysplastic syndrome 

UNSW Sydney 

Epigenetic biomarkers in breast cancer patient plasma 

Garvan Institute of Medical Research 

Autophagy in gastric carcinogenesis 

UNSW Sydney 

Developing a liquid biopsy for multiple myeloma 

UTS 

Investigating novel therapeutic targets and approaches in preclinical models of pancreatic cancer 

UNSW Sydney 

Investigating blood biomarkers for pancreatic cancer 

University of Newcastle 

Identification and characterization of biomarkers in endometrial cancer 

University of Newcastle 

Investigating mucinous tumours of the ovary and gastrointestinal tract 

UNSW Sydney 

Identifying cell type specific gene regulatory mechanisms in soft-tissue sarcomas 

UNSW Sydney 

Investigating obesity-related endometrial cancer 

UNSW Sydney 

Identifying a biomarker in osteosarcoma 

UNSW Sydney